comprehensive -WSS

comprehensive

author：fashion 2025-09-30 09:50:45 Page View：34

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Stanford president's case begs question: Who takes blame?
Next article： As demand for Covid shots wanes, Moderna seeks its next success

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

FDA seeks to regulate lab

AdobeTheFoodandDrugAdministrationonFridayannounceditsintentiontostartregulatingtestsdevelopedinlabor

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

1:30PoliceofficerscoordinatethesearchforawildanimalinaresidentialareainTeltow,Germany,ThursdayJuly20

comprehensive

knowledge

explore

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search